SF3A1 antibody: A301-601A


Antibody Info
Product_IDA301-601A
Lot_ID1
Host_organismrabbit
SourceBethyl Labs
Antibody_DCC_IDENCAB549NKF
Target Info
GeneNameSF3A1
Phosphate
Target_nameSF3A1-human

Validation Images
Cell linePrimary validationSecondary validation
HepG2 SF3A1-HEPG2-CRISPR-A301-601A.png<br>Caption: Western blot following CRISPR against SF3A1 in HepG2 whole cell lysate using SF3A1 specific antibody. Lane 1 is a ladder, lane 2 is HepG2 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against SF3A1. SF3A1 protein appears as the green arrow, GAPDH serves as a control and appears in red arrow.

Caption: Western blot following CRISPR against SF3A1 in HepG2 whole cell lysate using SF3A1 specific antibody. Lane 1 is a ladder, lane 2 is HepG2 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against SF3A1. SF3A1 protein appears as the green arrow, GAPDH serves as a control and appears in red arrow.

Releated Sample: BGHcLV18-43

Status: Released

Lab: Graveley Lab

K562 Bethyl_A301-601A_1_SF3A1.png<br>Caption: IP-WB analysis of K562 whole cell lysate using the SF3A1 specific antibody, A301-601A. Lane 1 is 2.5% of five million whole cell lysate input. Lanes 2 and 3 are 50% of IP enrichment from five million whole cell lysate using normal IgG antibody and the SF3A1-specific antibody, A301-601A. The same antibody was used to detect protein levels via Western blot. This antibody passes preliminary validation and will be further pursued for secondary validation. *NOTE* Protein sizes are taken from Genecards.org and are only estimates based on sequence. Actual protein size may differ based on protein characteristics and electrophoresis method used.

Caption: IP-WB analysis of K562 whole cell lysate using the SF3A1 specific antibody, A301-601A. Lane 1 is 2.5% of five million whole cell lysate input. Lanes 2 and 3 are 50% of IP enrichment from five million whole cell lysate using normal IgG antibody and the SF3A1-specific antibody, A301-601A. The same antibody was used to detect protein levels via Western blot. This antibody passes preliminary validation and will be further pursued for secondary validation. *NOTE* Protein sizes are taken from Genecards.org and are only estimates based on sequence. Actual protein size may differ based on protein characteristics and electrophoresis method used.

Comments: Band seen in lanes 2 and 3 indicates IgG heavy chain of antibody used in immunoprecipitation.

Method: immunoblot

Status: Released

Lab: Yeo Lab

SF3A1-K562-CRISPR-A301-601A.png<br>Caption: Western blot following CRISPR against SF3A1 in K562 whole cell lysate using SF3A1 specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against SF3A1. SF3A1 protein appears as the green arrow, GAPDH serves as a control and appears in red arrow.

Caption: Western blot following CRISPR against SF3A1 in K562 whole cell lysate using SF3A1 specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against SF3A1. SF3A1 protein appears as the green arrow, GAPDH serves as a control and appears in red arrow.

Releated Sample: BGKcLV17-45

Status: Released

Lab: Graveley Lab